Each tablet contains Allylestrenol INN 5 mg.
Allylestrenol is an orally active progestogen. Allylestrenol has a pronounced pregnancy maintaining action without producing hormonal side-effects. In the premature termination of pregnancy maintaining action without producing hormonal side-effects. In the premature termination of pregnancy often follows a fall in the levels of placental hormones. Alia has been shown to stimulate the placental progesterone production in vitro & to promote the secretion of placental hormones (chorionic gonadotrophin, placental lactogen, oestrogens and progesterone) and oxytocinase in patients with pregnancy at risk. In agreement to this the trophoblastic layers of the placenta show histological signs of activation. Clinical studies have indicated that Alia is an effective & safe pregnancy preparation. Administration of Alia in combination with bed rest can remove or prevent the threat of abortion in early pregnancy or stop threatened premature labor.
Alia is indicated for:
Route of Administration: Orally.
The dose of the drug depends on the indication.
OR AS DIRECTED BY THE PHYSICIAN.
Overdose:
If you have taken several tablet at once, there is no need for great concern. However, you should consult your doctor.
Alia (Allylestrenol) is specifically designed to be taken during pregnancy and it is safe in pregnancy serious adverse reaction have neither been reported in mother. It should be discontinued after delivery as it may affect nursing infant.
Not recommended.
Patients with the following conditions should be cautious:
Heart disease, congestive heart failure, sick sinus syndrome, coronary artery disease, seizures, epilepsy, renal dysfunction, migraine headaches, or breathing diseases including asthma, emphysema, chronic bronchitis or COPD, breast feeding.
Store below 30°C, protected from light & moisture.
Keep all medicines out of reach of children.